Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy

Cell Reports

Volumn 14, Issue 9, 2016, Pages 2209-2223

  Kanagawa, Motoi ^a   Kobayashi, Kazuhiro ^a   Tajiri, Michiko ^b   Manya, Hiroshi ^c   Kuga, Atsushi ^a   Yamaguchi, Yoshiki ^d   Akasaka Manya, Keiko ^c   Furukawa, Jun ichi ^e   Mizuno, Mamoru ^f   Kawakami, Hiroko ^f   Shinohara, Yasuro ^e   Wada, Yoshinao ^b   Endo, Tamao ^c   Toda, Tatsushi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

^d RIKEN   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f NOGUCHI INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; FUKUTIN; FUKUTIN RELATED PROTEIN; ISOPRENOID SYNTHASE DOMAIN; ORGANOPHOSPHATE; PHOSPHATE; RIBITOL 5 PHOSPHATE; RIBITOL 5 PHOSPHATE TRANSFERASE; RIBITOL PHOSPHATE; SYNTHETASE; TRANSFERASE; UNCLASSIFIED DRUG; FKRP PROTEIN, HUMAN; FKTN PROTEIN, HUMAN; ISPD PROTEIN, HUMAN; MEMBRANE PROTEIN; NUCLEOTIDYLTRANSFERASE; PENTOSE PHOSPHATE; PROTEIN; RIBITOL-5-PHOSPHATE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; GLYCOSYLATION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MUSCULAR DYSTROPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN PROCESSING; AMINO ACID SEQUENCE; CARBOHYDRATE ANALYSIS; CONFORMATION; ENZYMOLOGY; GENETICS; HEK293 CELL LINE; METABOLISM; MUTATION; PHYSIOLOGY;

AMINO ACID SEQUENCE; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; GLYCOSYLATION; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; MUSCULAR DYSTROPHIES; MUTATION; NUCLEOTIDYLTRANSFERASES; PENTOSEPHOSPHATES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 84960448786     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.02.017     Document Type: Article

References (44)

1. Ackroyd M.R., Skordis L., Kaluarachchi M., Godwin J., Prior S., Fidanboylu M., Piercy R.J., Muntoni F., Brown S.C. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. Brain 2009, 132:439-451.
2. Aravind L., Koonin E.V. The fukutin protein family--predicted enzymes modifying cell-surface molecules. Curr. Biol. 1999, 9:R836-R837.
3. Bao X., Kobayashi M., Hatakeyama S., Angata K., Gullberg D., Nakayama J., Fukuda M.N., Fukuda M. Tumor suppressor function of laminin-binding α-dystroglycan requires a distinct β3-N-acetylglucosaminyltransferase. Proc. Natl. Acad. Sci. USA 2009, 106:12109-12114.
4. Baur S., Marles-Wright J., Buckenmaier S., Lewis R.J., Vollmer W. Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcus pneumoniae. J. Bacteriol. 2009, 191:1200-1210.
5. Brockington M., Blake D.J., Prandini P., Brown S.C., Torelli S., Benson M.A., Ponting C.P., Estournet B., Romero N.B., Mercuri E., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am. J. Hum. Genet. 2001, 69:1198-1209.
6. Brockington M., Yuva Y., Prandini P., Brown S.C., Torelli S., Benson M.A., Herrmann R., Anderson L.V., Bashir R., Burgunder J.M., et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 2001, 10:2851-2859.
7. Brown S., Santa Maria J.P., Walker S. Wall teichoic acids of gram-positive bacteria. Annu. Rev. Microbiol. 2013, 67:313-336.
8. Cao W., Henry M.D., Borrow P., Yamada H., Elder J.H., Ravkov E.V., Nichol S.T., Compans R.W., Campbell K.P., Oldstone M.B. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 1998, 282:2079-2081.
9. Chiba A., Matsumura K., Yamada H., Inazu T., Shimizu T., Kusunoki S., Kanazawa I., Kobata A., Endo T. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J. Biol. Chem. 1997, 272:2156-2162.
10. Cirak S., Foley A.R., Herrmann R., Willer T., Yau S., Stevens E., Torelli S., Brodd L., Kamynina A., Vondracek P., et al. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain 2013, 136:269-281. UK10K Consortium.
11. Cohn R.D., Henry M.D., Michele D.E., Barresi R., Saito F., Moore S.A., Flanagan J.D., Skwarchuk M.W., Robbins M.E., Mendell J.R., et al. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 2002, 110:639-648.
12. Esapa C.T., Benson M.A., Schröder J.E., Martin-Rendon E., Brockington M., Brown S.C., Muntoni F., Kröger S., Blake D.J. Functional requirements for fukutin-related protein in the Golgi apparatus. Hum. Mol. Genet. 2002, 11:3319-3331.
13. Goddeeris M.M., Wu B., Venzke D., Yoshida-Moriguchi T., Saito F., Matsumura K., Moore S.A., Campbell K.P. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature 2013, 503:136-140.
14. Hara Y., Balci-Hayta B., Yoshida-Moriguchi T., Kanagawa M., Beltrán-Valero de Bernabé D., Gündeşli H., Willer T., Satz J.S., Crawford R.W., Burden S.J., et al. A dystroglycan mutation associated with limb-girdle muscular dystrophy. N. Engl. J. Med. 2011, 364:939-946.
15. Hara Y., Kanagawa M., Kunz S., Yoshida-Moriguchi T., Satz J.S., Kobayashi Y.M., Zhu Z., Burden S.J., Oldstone M.B.A., Campbell K.P. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Proc. Natl. Acad. Sci. USA 2011, 108:17426-17431.
16. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992, 355:696-702.
17. Inamori K., Yoshida-Moriguchi T., Hara Y., Anderson M.E., Yu L., Campbell K.P. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 2012, 335:93-96.
18. Jae L.T., Raaben M., Riemersma M., van Beusekom E., Blomen V.A., Velds A., Kerkhoven R.M., Carette J.E., Topaloglu H., Meinecke P., et al. Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science 2013, 340:479-483.
19. Kanagawa M., Saito F., Kunz S., Yoshida-Moriguchi T., Barresi R., Kobayashi Y.M., Muschler J., Dumanski J.P., Michele D.E., Oldstone M.B.A., Campbell K.P. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 2004, 117:953-964.
20. Kanagawa M., Yu C.C., Ito C., Fukada S., Hozoji-Inada M., Chiyo T., Kuga A., Matsuo M., Sato K., Yamaguchi M., et al. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression. Hum. Mol. Genet. 2013, 22:3003-3015.
21. Kobayashi K., Nakahori Y., Miyake M., Matsumura K., Kondo-Iida E., Nomura Y., Segawa M., Yoshioka M., Saito K., Osawa M., et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998, 394:388-392.
22. Kuchta K., Knizewski L., Wyrwicz L.S., Rychlewski L., Ginalski K. Comprehensive classification of nucleotidyltransferase fold proteins: identification of novel families and their representatives in human. Nucleic Acids Res. 2009, 37:7701-7714.
23. Kuga A., Kanagawa M., Sudo A., Chan Y.M., Tajiri M., Manya H., Kikkawa Y., Nomizu M., Kobayashi K., Endo T., et al. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan. J. Biol. Chem. 2012, 287:9560-9567.
24. Kurahashi H., Taniguchi M., Meno C., Taniguchi Y., Takeda S., Horie M., Otani H., Toda T. Basement membrane fragility underlies embryonic lethality in fukutin-null mice. Neurobiol. Dis. 2005, 19:208-217.
25. Manya H., Chiba A., Yoshida A., Wang X., Chiba Y., Jigami Y., Margolis R.U., Endo T. Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. Proc. Natl. Acad. Sci. USA 2004, 101:500-505.
26. Matsumoto H., Hayashi Y.K., Kim D.S., Ogawa M., Murakami T., Noguchi S., Nonaka I., Nakazawa T., Matsuo T., Futagami S., et al. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan. Neuromuscul. Disord. 2005, 15:342-348.
27. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., Dollar J., Nishino I., Kelley R.I., Somer H., et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 2002, 418:417-422.
28. Miller M.R., Ma D., Schappet J., Breheny P., Mott S.L., Bannick N., Askeland E., Brown J., Henry M.D. Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma. Mol. Cancer 2015, 14:141.
29. Mo K.F., Fang T., Stalnaker S.H., Kirby P.S., Liu M., Wells L., Pierce M., Live D.H., Boons G.J. Synthetic, structural, and biosynthetic studies of an unusual phospho-glycopeptide derived from α-dystroglycan. J. Am. Chem. Soc. 2011, 133:14418-14430.
30. Moore S.A., Saito F., Chen J., Michele D.E., Henry M.D., Messing A., Cohn R.D., Ross-Barta S.E., Westra S., Williamson R.A., et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 2002, 418:422-425.
31. Negm F.B., Marlow G.C. Partial purification and characterization of d-ribose-5-phosphate reductase from Adonis vernalis L. Leaves. Plant Physiol. 1985, 78:758-761.
32. Praissman J.L., Live D.H., Wang S., Ramiah A., Chinoy Z.S., Boons G.J., Moremen K.W., Wells L. B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan. eLife 2014, 3:e03943.
33. Quijano-Roy S., Martí-Carrera I., Makri S., Mayer M., Maugenre S., Richard P., Berard C., Viollet L., Leheup B., Guicheney P., et al. Brain MRI abnormalities in muscular dystrophy due to FKRP mutations. Brain Dev. 2006, 28:232-242.
34. Roscioli T., Kamsteeg E.J., Buysse K., Maystadt I., van Reeuwijk J., van den Elzen C., van Beusekom E., Riemersma M., Pfundt R., Vissers L.E.L.M., et al. Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan. Nat. Genet. 2012, 44:581-585.
35. Singh J., Itahana Y., Knight-Krajewski S., Kanagawa M., Campbell K.P., Bissell M.J., Muschler J. Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res. 2004, 64:6152-6159.
36. Tachikawa M., Kanagawa M., Yu C.C., Kobayashi K., Toda T. Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration. J. Biol. Chem. 2012, 287:8398-8406.
37. Taniguchi-Ikeda M., Kobayashi K., Kanagawa M., Yu C.C., Mori K., Oda T., Kuga A., Kurahashi H., Akman H.O., DiMauro S., et al. Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 2011, 478:127-131.
38. Wiggins C.A., Munro S. Activity of the yeast MNN1 alpha-1,3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. Proc. Natl. Acad. Sci. USA 1998, 95:7945-7950.
39. Willer T., Lee H., Lommel M., Yoshida-Moriguchi T., de Bernabe D.B., Venzke D., Cirak S., Schachter H., Vajsar J., Voit T., et al. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat. Genet. 2012, 44:575-580.
40. Willer T., Inamori K., Venzke D., Harvey C., Morgensen G., Hara Y., Beltrán Valero de Bernabé D., Yu L., Wright K.M., Campbell K.P. The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation. eLife 2014, 3:e03941.
41. Yoshida A., Kobayashi K., Manya H., Taniguchi K., Kano H., Mizuno M., Inazu T., Mitsuhashi H., Takahashi S., Takeuchi M., et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell 2001, 1:717-724.
42. Yoshida-Moriguchi T., Campbell K.P. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology 2015, 25:702-713.
43. Yoshida-Moriguchi T., Yu L., Stalnaker S.H., Davis S., Kunz S., Madson M., Oldstone M.B.A., Schachter H., Wells L., Campbell K.P. O-mannosyl phosphorylation of α-dystroglycan is required for laminin binding. Science 2010, 327:88-92.
44. Yoshida-Moriguchi T., Willer T., Anderson M.E., Venzke D., Whyte T., Muntoni F., Lee H., Nelson S.F., Yu L., Campbell K.P. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function. Science 2013, 341:896-899.